Leading Bio-Pharma Company Improves Control and Transparency of Healthcare Professional Spend

In evaluating its compliance with the Physician Payments Sunshine Act, this global bio-pharmaceutical organization’s cross-functional team discovered multiple, non-integrated data tracking methods and systems throughout the enterprise. With processes and systems scattered across the enterprise, there was no standard mechanism to ensure that the business processes and systems were accurately and efficiently capturing the data to meet the requirements of the proposed legislation.

Learn how, with Pega, this bio-pharma company is now able to meet federal and state regulatory compliance reporting requirements while achieving visibility, control, and transparency of HCP spend across the enterprise.